ARGUMENTS AND FACTS ON CORONAVIRUS (COVID-2019)
Abstract
A new public health crisis is emerging, threatening the world with the emergence and spread of the new coronavirus 2019 (2019-nCoV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus originated in bats and was transmitted to humans through unknown intermediary animals in Wuhan, Hubei Province, China, in December 2019. The disease is transmitted by inhalation or contact with infected droplets, and the incubation period ranges from 2 to 14 days. Symptoms are usually fever, cough, sore throat, shortness of breath, fatigue, malaise and others. The disease is moderate in most people; in some (usually elderly people and people with concomitant diseases), it can progress to pneumonia, acute respiratory distress syndrome (ARDS) and multiple organ dysfunction. Many people are asymptomatic. It is estimated that the mortality rate is from 2 to 3%. The treatment is essentially supportive (for now). Prevention includes isolation at home, as well as strict infection control measures in hospitals. The virus spreads faster than its two ancestors - SARS-CoV and the Middle East Respiratory syndrome coronavirus (MERS-CoV), but has a lower mortality rate.
About the Authors
N. T. Jainakbayev
NEI «Kazakh-Russian Medical University»
Kazakhstan
Kazakhstan
MD, Professor
K. O. Sharipov
NEI «Kazakh-Russian Medical University»
Kazakhstan
Kazakhstan
MD, Professor
References
1. Coronaviridae Virus Taxonomy: 2018 b Release) https://talk.ictvonline.org2February2020.
2. Anthony R. Fehr, Stanley Perlman. Coronaviruses: An Overview of Their Replication and Pathogenesis. // In book: Methods in Molecular Biology. – 2015. – Vol. 1282. - P. 1-23.
3. Arabi Y., Balkhy H., Hayden F. et al. Middle East respiratory syndrome. // N Engl J Med. – 2017. – Vol. 376 (6). – P. 584–594.
4. Azhar E., Hui D., Memish Z. et al. The Middle East respiratory syndrome (MERS). // Infect Dis Clin North Am. – 2019. – Vol. 33(4). – P. 891–905.
5. Cui J., Li F., Shi Z. Origin and evolution of pathogenic coronaviruses. // Nat Rev Microbiol. – 2019. – Vol. 17(3). – P.181–192/.
6. Hui D., Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. // Infect Dis Clin North Am. – 2019. – Vol. 33(4). – P. 869–889.
7. Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. // Nature. – 2020. – Vol.579. – P.270- 289. doi:10.1038/s41586-020-2012-7.
8. Zhao L., Jha B.K., Wu A. et al. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. // Cell Host Microbe. – 2012. – Vol. 11. – P.607–616. doi:10.1016/j.chom.2012.04.011.
9. Barcena M., Oostergetel G.T., Bartelink W. et al. Cryoelectron tomography of mouse hepatitis virus: insights into the structure of the coronavirion. // Proc Natl Acad Sci USA. – 2009. – Vol. 106. – P.582 – 587.
10. Neuman B.W., Adair B.D., Yoshioka C. Et al. Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. // J. Virol. – 2006. - Vol. 80. – P.7918–7928.
11. Bosch B.J., van der Zee R., de Haan C.A. et al. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. // J Virol. – 2003. – Vol. 77. – P. 801–8811.
12. Nal B., Chan C., Kien F. Et al. Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. // J Gen Virol. - 2005. – Vol. 86. – P.1423–1434. doi: 10.1099/ vir.0.80671-0.
13. Neuman B.W., Kiss G., Kunding A.H. et al. A structural analysis of M protein in coronavirus assembly and morphology. // J Struct Biol. – 2011. – Vol. 174. – P.11–22. doi: 10.1016/j.jsb.2010.11.021.
14. Chang C.K., Sue S.C., Yu T.H. et al. Modular organization of SARS coronavirus nucleocapsid protein. // J Biomed Sci. - 2006. – Vol. 13. – P.59–72. doi: 10.1007/ s11373-005-9035-9.
15. Hurst K.R., Koetzner C.A., Masters P.S. Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein. // J Virol. – 2009. – Vol. 83. – P.7221– 7234. doi: 10.1128/ JVI.00440-09.
16. Stohlman S.A., Baric R.S., Nelson G.N. et al. Specific interaction between coronavirus leader RNA and nucleocapsid protein. // J Virol. – 1988. – Vol. 62. – P.4288–4295.
17. Molenkamp R., Spaan W.J. Identification of a specifi c interaction between the coronavirus mouse hepatitis virus A59 nucleocapsid protein and packaging signal. // Virology – 1997. – Vol. 239. – P.78–86.
18. Kuo L., Masters P.S. Functional analysis of the murine coronavirus genomic RNA packaging signal. // J Virol. – 2013. – Vol. 87. – P.5182–5192. doi: 10.1128/JVI.00100-13.
19. Hurst K.R., Koetzner C.A., Masters P.S. Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicasetranscriptase complex. // J Virol. – 2013. - Vol.87. – P.9159– 9172. doi: 10.1128/JVI.01275-13.
20. Sturman L.S., Holmes K.V., Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. // J Virol. - 1980. – Vol. 33. – P.449–462.
21. Xiaolu Tang, Changcheng Wu, Xiang Li, Yuhe Song, Xinmin Yao. On the origin and continuing evolution of SARS-CoV-2 (англ.) // National Science Review. – 2020. - doi:10.1093/nsr/nwaa036.
22. GenBank MN908947, Ref Ceq NC_045512. SARSCoV- 2 (Severe acute respiratory syndrome coronavirus 2).
23. Rothe C., Schunk M., Sothmann P., et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2001468.
24. Zou L., Ruan F., Huang M., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2001737.
25. Kampf G., Todt D., Pfaender S., Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. 2020 Feb 6. pii: S0195–6701(20) 30046–3.
26. Chen H., Guo J., Wang C., et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30360-3.
27. Koyama T., Platt D. & Parida L. Variant analysis of COVID-19 genomes. // Bull World Health Organ. E-pub: 24 February 2020. doi: http://dx.doi.org/10.2471/BLT.20.253591).
28. Клинический протокол диагностики и лечения коронавирусной инфекции от 1 апреля 2020 года (Одобрено комиссий протоколом 89 МЗ РК).
Review
For citations:
Jainakbayev N.T., Sharipov K.O. ARGUMENTS AND FACTS ON CORONAVIRUS (COVID-2019). Actual Problems of Theoretical and Clinical Medicine. 2020;(1):37-41. (In Russ.)
Views:
192
